Inactive Instrument

News Propanc Biopharma Inc Other OTC

Equities

US74346N1072

Summary

Unlock all the news: Be the first to know and act before the market!

Propanc Biopharma Receives Certificate of Grant for Proenzymes Composition Patent from Japanese Patent Office	Jun. 26	AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for "Proenzymes Composition" Patent from Japanese Patent Office	Jun. 25	CI
Propanc Biopharma, Inc. announced that it has received $0.03375 million in funding	Jun. 19	CI
Propanc Biopharma, Inc. announced that it has received $0.041 million in funding from 1800 Diagonal Lending, LLC	Jun. 16	CI
Propanc Biopharma, Inc. Enters into and Closed a Loan Agreement with an Investor	Jun. 13	CI
Propanc Biopharma, Inc. announced that it has received $0.041 million in funding from 1800 Diagonal Lending, LLC	May. 30	CI
Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 15	CI
Propanc Biopharma : Material Agreement - Form 8-K	Apr. 22	PU
Propanc Biopharma Receives Certificate of Grant for Composition of Proenzymes for Cancer Treatment Patent from European Patent Office	Apr. 17	AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	Apr. 16	CI
Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC	Apr. 15	CI
Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment, an inside Look at Drug Development and Strategic Financing	Apr. 09	AQ
Propanc Biopharma : Material Agreement - Form 8-K	Mar. 11	PU
Propanc Biopharma, Inc. announced that it has received $0.046875 million in funding	Feb. 29	CI
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study	Feb. 23	AQ
Propanc Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 20	CI
Propanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Office	Jan. 16	CI
Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP	Dec. 14	AQ
Propanc Biopharma, Inc. announced that it has received $0.135 million in funding	Dec. 10	CI
Propanc Biopharma, Inc. announced that it has received $0.045 million in funding	Dec. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Propanc Biopharma Inc Other OTC

Equities

US74346N1072

Summary

Filters